Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation

Completed · Not applicable

Conditions studied: COVID-19

In brief

Q-POC SARS-CoV-2 moderate complexity PCR test performance evaluation

Key facts

Study ID

NCT05614011

Run by

QuantuMDx Group Ltd

People needed

877

Starts

2022-11-28

Expected to finish

2023-05-17

Last updated by the study team

2024-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must be over the age of 18 years.
• Participants must present with symptoms indicative of SARS-CoV-2 infection, within 0-5 days of symptom onset.
• Participants must have capacity to give informed consent.

You may not qualify if…

• Participant is under the age of 18 years.
• Participant does not have symptoms of SARS-CoV-2 infection.
• Participant lacks capacity to give informed consent.

Where it is running

• Bright Research Center — Miami, Florida, United States
• EDP Biotech — Knoxville, Tennessee, United States
• PathAI — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.